BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 20079187)

  • 21. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
    Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
    Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
    Younes SF; Aiad H; Kandil M; El Kalashy FS
    Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
    Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
    Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
    Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
    Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma].
    Zhao JH; Wan XY; Xie X; Zhou CY; Wu QY
    Ai Zheng; 2006 Jun; 25(6):753-7. PubMed ID: 16764775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
    Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
    Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
    Li XC; Song WJ
    Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia.
    Trabzonlu L; Muezzinoglu B; Corakci A
    Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
    Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
    Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
    Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H; Naudé S
    Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
    Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
    Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
    Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
    Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
    Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
    Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas.
    Wappenschmidt B; Wardelmann E; Gehrig A; Schöndorf T; Maass N; Bonatz G; Gassel AM; Pietsch T; Mallmann P; Weber BH; Schmutzler RK
    Hum Pathol; 2004 Oct; 35(10):1260-5. PubMed ID: 15492994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.